Asmanex is indicated for the maintenance treatment of asthma as prophylactic therapy in patients four years of age and older, and is said to be the first and only once-daily inhaled corticosteroid inhaler approved for this use in children as young as four.
Asmanex was approved for children ages four to 11 by the FDA in February 2008. It is not indicated for the relief of sudden asthma symptoms or in children less than four years of age.